Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02209181 · ClinicalTrials.gov registry record · Phase 2
A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine
A Phase 2 study, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.
- Completed
- Registry status
- Phase 2
- Development phase
- 269
- Enrollment target
NCT02209181: Completed Phase 2 study, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.
NCT02209181 is a Phase 2 study that has completed, run by McNeil Consumer Healthcare Division of McNEIL-PPC. The registered enrollment target is 269 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02209181, a Phase 2 study, has completed, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 269 participants
- Enrollment target
Study Summary
To assess the safety and effectiveness one dose of a new pain reliever medicine (JNJ-10450232 at either the 250 or 1000 mg strength) compared with placebo (sugar pill) or acetaminophen 1000 mg after surgical removal of third molars. The primary endpoint will evaluate pain relief effectiveness up to 6 hours after administration of the study drug.
Interventions
- DRUG JNJ-10450232 / Not yet marketed
- DRUG acetaminophen / Tylenol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02209181
The ClinicalTrials.gov registry entry for NCT02209181 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McNeil Consumer Healthcare Division of McNEIL-PPC, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which JNJ-10450232 / Not yet marketed is the first listed.
NCT02209181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02209181 about?
NCT02209181 is a clinical study titled "A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine". To assess the safety and effectiveness one dose of a new pain reliever medicine (JNJ-10450232 at either the 250 or 1000 mg strength) compared with placebo (sugar pill) or acetaminophen 1000 mg after surgical removal of third molars. The primary endpoint will evaluate pain relief effectiveness up to ...
What is the current status of trial NCT02209181?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 269 participants. The study started on 2014-08. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02209181?
The interventions under investigation include: JNJ-10450232 / Not yet marketed (DRUG), acetaminophen / Tylenol (DRUG).
Who is sponsoring clinical trial NCT02209181?
This trial is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.